Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkat Bhat

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Journal of Neuroscience Methods|April 3, 2026
EEG-AI: An Agentic System for AI-Assisted Semi-Automated EEG Preprocessing and Artifact RemovalAbdelrahman Abdou, Martin Ivanov, Sarmed Shaya, et al.
The Journal of ECT|September 14, 2021
Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National SurveyIlya Demchenko, Daniel M Blumberger, Alastair J Flint, et al.
Psychotherapy and Psychosomatics|January 30, 2026
Adherence to Physical Activity Interventions in Major Depressive Disorder: A Systematic Review and Meta-AnalysisVanessa K Tassone, Qiaowei Lin, Gloria Li, et al.
Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Journal of Affective Disorders|January 25, 2026
Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modelingReinhard Janssen-Aguilar, Jithin Joseph, Huda Al-Shamali, et al.
Brain : a Journal of Neurology|July 29, 2021
Structuro-functional surrogates of response to subcallosal cingulate deep brain stimulation for depressionGavin J B Elias, Jürgen Germann, Alexandre Boutet, et al.
CNS Drugs|April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.
Brain and Behavior|July 10, 2025
Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic ReviewShakila Meshkat, Corinna Di Luciano, Alyssa Swiderski, et al.
Brain : a Journal of Neurology|December 17, 2021
3T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulationGavin J B Elias, Jürgen Germann, Alexandre Boutet, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Journal of Neuroscience Methods|April 3, 2026
EEG-AI: An Agentic System for AI-Assisted Semi-Automated EEG Preprocessing and Artifact RemovalAbdelrahman Abdou, Martin Ivanov, Sarmed Shaya, et al.
The Journal of ECT|September 14, 2021
Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National SurveyIlya Demchenko, Daniel M Blumberger, Alastair J Flint, et al.
Psychotherapy and Psychosomatics|January 30, 2026
Adherence to Physical Activity Interventions in Major Depressive Disorder: A Systematic Review and Meta-AnalysisVanessa K Tassone, Qiaowei Lin, Gloria Li, et al.
Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Journal of Affective Disorders|January 25, 2026
Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modelingReinhard Janssen-Aguilar, Jithin Joseph, Huda Al-Shamali, et al.
Brain : a Journal of Neurology|July 29, 2021
Structuro-functional surrogates of response to subcallosal cingulate deep brain stimulation for depressionGavin J B Elias, Jürgen Germann, Alexandre Boutet, et al.
CNS Drugs|April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.
Brain and Behavior|July 10, 2025
Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic ReviewShakila Meshkat, Corinna Di Luciano, Alyssa Swiderski, et al.
Brain : a Journal of Neurology|December 17, 2021
3T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulationGavin J B Elias, Jürgen Germann, Alexandre Boutet, et al.
Pageof 14